Home » Newsletters » BioWorld

BioWorld

Feb. 25, 1992

View Archived Issues

TSI SHARES ELIGIBLE FOR CONVERSION

CAMBRIDGE BIO ENTERS PRIVATE LABEL PACT

ONCOTECH TO DEVELOP IMUVERT

CIBA TO TEST APHTON IMMUNE STIMULANTS

MEDICIS WARRANT REDEMPTION RAISES $14M

MYCOGEN ADOPTS POISON PILL

SOMATOGEN BLOOD SUBSTITUTE ENTERS TRIALS

ICOS BACK TO THE FUNDING WELL

GRANT FOR DNA IDENTIFICATION SYSTEM

MGI FILES FOR SALAGEN APPROVAL

RISK POLICY PAVES WAY FOR BIOTECH RULES